Pages

Tuesday, March 28, 2017

FDA approves 1st drug for moderate & severe eczema cases

... list price of $37,000 per year, according to Paris, France-based Sanofi SA and Regeneron Pharmaceuticals of Tarrytown, New York, which developed the drug. Side effects can include cold sores and inflammation of the eye and eyelid. The drug is an ...
http://ift.tt/2o3xpOz

No comments:

Post a Comment